Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (281-290 of 293) with videos related to

Pageof 30
Sort By:
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Cardiovascular Diabetology|May 7, 2026
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuumOliver Schnell, Arnav Agarwal, Michel Azizi, et al.
Journal of Hepatology|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Hepatology (Baltimore, Md.)|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Annals of Hepatology|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Gut|March 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetesYuping Chen, Bingtian Dong, Xinrui Jin, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2024
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter StudyGong Feng, Ferenc E Mózes, Dong Ji, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 27, 2025
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLDXiao-Dong Zhou, Yu-Ting Li, Seung Up Kim, et al.
Pageof 30

Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Cardiovascular Diabetology|May 7, 2026
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuumOliver Schnell, Arnav Agarwal, Michel Azizi, et al.
Journal of Hepatology|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Hepatology (Baltimore, Md.)|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Annals of Hepatology|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Gut|March 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetesYuping Chen, Bingtian Dong, Xinrui Jin, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2024
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter StudyGong Feng, Ferenc E Mózes, Dong Ji, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 27, 2025
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLDXiao-Dong Zhou, Yu-Ting Li, Seung Up Kim, et al.
Pageof 30